Clinical Trial Update: Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carboplatin plus irinotecan for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: NYU Langone Health | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED